Zimran A - Search Results

1

Attitudes of couples identified through screening as carriers of Gaucher disease type 1.

Zuckerman S, Lahad A, Zimran A, Levy-Lahad E, Sagi M. Zuckerman S, et al. Among authors: zimran a. Clin Genet. 2008 Dec;74(6):566-70. doi: 10.1111/j.1399-0004.2008.01063.x. Epub 2008 Jul 21. Clin Genet. 2008. PMID: 18651845

2

High frequency of the Gaucher disease mutation at nucleotide 1226 among Ashkenazi Jews.

Zimran A, Gelbart T, Westwood B, Grabowski GA, Beutler E. Zimran A, et al. Am J Hum Genet. 1991 Oct;49(4):855-9. Am J Hum Genet. 1991. PMID: 1897529 Free PMC article.

3

Replacement therapy with imiglucerase for type 1 Gaucher's disease.

Zimran A, Elstein D, Levy-Lahad E, Zevin S, Hadas-Halpern I, Bar-Ziv Y, Foldes J, Schwartz AJ, Abrahamov A. Zimran A, et al. Lancet. 1995 Jun 10;345(8963):1479-80. doi: 10.1016/s0140-6736(95)91038-7. Lancet. 1995. PMID: 7769903 Clinical Trial.

4

Low-dose high-frequency enzyme replacement therapy for very young children with severe Gaucher disease.

Zimran A, Hadas-Halpern I, Zevin S, Levy-Lahad E, Abrahamov A. Zimran A, et al. Br J Haematol. 1993 Dec;85(4):783-6. doi: 10.1111/j.1365-2141.1993.tb03224.x. Br J Haematol. 1993. PMID: 7918044

5

Low-dose enzyme replacement therapy for Gaucher's disease: effects of age, sex, genotype, and clinical features on response to treatment.

Zimran A, Elstein D, Kannai R, Zevin S, Hadas-Halpern I, Levy-Lahad E, Cohen Y, Horowitz M, Abrahamov A. Zimran A, et al. Am J Med. 1994 Jul;97(1):3-13. doi: 10.1016/0002-9343(94)90042-6. Am J Med. 1994. PMID: 8030654

6

Adult-type Gaucher disease in children: genetics, clinical features and enzyme replacement therapy.

Zevin S, Abrahamov A, Hadas-Halpern I, Kannai R, Levy-Lahad E, Horowitz M, Zimran A. Zevin S, et al. Among authors: zimran a. Q J Med. 1993 Sep;86(9):565-73. Q J Med. 1993. PMID: 8255971 Review.

7

Prenatal molecular diagnosis of Gaucher disease.

Zimran A, Elstein D, Abrahamov A, Kuhl W, Brown KH, Beutler E. Zimran A, et al. Prenat Diagn. 1995 Dec;15(12):1185-8. doi: 10.1002/pd.1970151219. Prenat Diagn. 1995. PMID: 8750303

8

Effect of low-dose enzyme replacement therapy on bones in Gaucher disease patients with severe skeletal involvement.

Elstein D, Hadas-Halpern I, Itzchaki M, Lahad A, Abrahamov A, Zimran A. Elstein D, et al. Among authors: zimran a. Blood Cells Mol Dis. 1996;22(2):104-11; discussion 112-4. doi: 10.1006/bcmd.1996.0016. Blood Cells Mol Dis. 1996. PMID: 8931951

9

Gaucher's disease: genetic counselling and population screening.

Levy-Lahad E, Zimran A. Levy-Lahad E, et al. Among authors: zimran a. Baillieres Clin Haematol. 1997 Dec;10(4):779-92. doi: 10.1016/s0950-3536(97)80040-6. Baillieres Clin Haematol. 1997. PMID: 9497864 Review.

10

Ethical considerations for enzyme replacement therapy in neuronopathic Gaucher disease.

Elstein D, Abrahamov A, Zimran A. Elstein D, et al. Among authors: zimran a. Clin Genet. 1998 Sep;54(3):179-84. doi: 10.1111/j.1399-0004.1998.tb04281.x. Clin Genet. 1998. PMID: 9788718

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

363 results

Search Page

Filters